Search Results - "MacKenzie, Erin M"

Refine Results
  1. 1

    Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews by Therrien, François, Meehan, Stine R., Weiss, Catherine, Dine, Jennifer, Brown, T. Michelle, MacKenzie, Erin M.

    Published in Journal of patient-reported outcomes (12-10-2022)
    “…Background Patient-reported outcomes can measure health aspects that are meaningful to patients, such as ‘life engagement’ in major depressive disorder (MDD)…”
    Get full text
    Journal Article
  2. 2

    Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine by Baker, Glen, Matveychuk, Dmitriy, MacKenzie, Erin M., Holt, Andrew, Wang, Yanlin, Kar, Satyabrata

    Published in Chemico-biological interactions (01-05-2019)
    “…Phenelzine (β-phenylethylhydrazine) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. It possesses a number of important…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies by Katzman, Martin A., Therrien, François, MacKenzie, Erin M., Wang, Fan, de Jong-Laird, Anne, Boucher, Matthieu

    Published in Journal of affective disorders (01-11-2022)
    “…Major depressive disorder (MDD) is a clinically heterogenous condition and its treatment should be individualized according to the presence of particular…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    An update on amine oxidase inhibitors: Multifaceted drugs by Song, Mee-Sook, Matveychuk, Dmitriy, MacKenzie, Erin M., Duchcherer, Maryana, Mousseau, Darrell D., Baker, Glen B.

    “…Although not used as extensively as other antidepressants for the treatment of depression, the monoamine oxidase (MAO) inhibitors continue to hold a niche in…”
    Get full text
    Journal Article
  8. 8

    The histology of sutures in chicken skulls: Types, conservation, and ontogeny by Arnaout, Bassel, MacKenzie, Erin M., Lantigua, Kayla E., Brzezinski, Kaylen, McKinnell, Iain W., Maddin, Hillary C.

    Published in Journal of anatomy (01-03-2022)
    “…Sutures are fibrous joints that occur between bone elements in vertebrate skulls, where they play a variety of roles including facilitating skull growth and…”
    Get full text
    Journal Article
  9. 9

    Normal development in Xenopus laevis: A complementary staging table for the skull based on cartilage and bone by MacKenzie, Erin M., Atkins, Jade B., Korneisel, Dana E., Cantelon, Alanna S., McKinnell, Iain W., Maddin, Hillary C.

    Published in Developmental dynamics (01-08-2022)
    “…Background Xenopus laevis is a widely used model organism in the fields of genetics and development, and more recently evolution. At present, the most widely…”
    Get full text
    Journal Article
  10. 10

    Development of the chicken skull: A complement to the external staging table of Hamburger and Hamilton by Arnaout, Bassel, Lantigua, Kayla E., MacKenzie, Erin M., McKinnell, Iain W., Maddin, Hillary C.

    Published in Anatomical record (Hoboken, N.J. : 2007) (01-12-2021)
    “…Embryonic staging tables provide a standard of developmental stages that can be used by individual investigators and provide approximate time points for the…”
    Get full text
    Journal Article
  11. 11

    Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine by Matveychuk, Dmitriy, MacKenzie, Erin M., Kumpula, David, Song, Mee-Sook, Holt, Andrew, Kar, Satyabrata, Todd, Kathryn G., Wood, Paul L., Baker, Glen B.

    Published in Cellular and molecular neurobiology (01-01-2022)
    “…Phenelzine (PLZ) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. This multifaceted drug has a number of pharmacological and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Monoamine oxidase inhibitors and neuroprotection: a review by Al-Nuaimi, Saleem K, Mackenzie, Erin M, Baker, Glen B

    Published in American journal of therapeutics (01-11-2012)
    “…Monoamine oxidase inhibitors have been available for more than 50 years, initially developed as antidepressants but currently used in a variety of psychiatric…”
    Get full text
    Journal Article
  14. 14

    Inhibition of p53 attenuates ischemic stress-induced activation of astrocytes by Ahn, Kee-Chan, MacKenzie, Erin M, Learman, Cameron R, Hall, Tia C, Weaver, Charles L, Dunbar, Gary L, Song, Mee-Sook

    Published in Neuroreport (30-09-2015)
    “…In cerebral ischemia, studies of cell death have focused primarily on neurons, but recent work indicates that ischemia also causes damage to astrocytes…”
    Get full text
    Journal Article
  15. 15

    The pharmacology and formulation of paliperidone extended release by Chue, Pierre S, MacKenzie, Erin M, Chue, James A, Baker, Glen B

    Published in Expert review of neurotherapeutics (01-12-2012)
    “…Paliperidone, or 9-hydroxyrisperidone (Invega(®), Janssen, Antwerp, Belgium) is the major active metabolite of the atypical antipsychotic risperidone…”
    Get more information
    Journal Article
  16. 16

    D-serine and schizophrenia: an update by Nunes, Emerson A, MacKenzie, Erin M, Rossolatos, David, Perez-Parada, Jorge, Baker, Glen B, Dursun, Serdar M

    Published in Expert review of neurotherapeutics (01-07-2012)
    “…Considering the lengthy history of pharmacological treatment of schizophrenia, the development of novel antipsychotic agents targeting the glutamatergic system…”
    Get more information
    Journal Article
  17. 17
  18. 18

    The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders by MacKenzie, Erin M, Odontiadis, John, Le Mellédo, Jean-Michel, Prior, Trevor I, Baker, Glen B I

    Published in Cellular and molecular neurobiology (01-07-2007)
    “…1. Neuroactive steroids are steroid hormones that exert rapid, nongenomic effects at ligand-gated ion channels. There is increasing awareness of the possible…”
    Get full text
    Journal Article
  19. 19

    Phenelzine Causes an Increase in Brain Ornithine that is Prevented by Prior Monoamine Oxidase Inhibition by MacKenzie, Erin M., Grant, Suzanne L., Baker, Glen B., Wood, Paul L.

    Published in Neurochemical research (01-03-2008)
    “…Phenelzine (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA…”
    Get full text
    Journal Article
  20. 20